Role of Nucleoside Transporters in Nucleoside-Derived Drug Sensitivity

REFERENCES

• Baldwin , S. A. , Beal , P. R. , Yao , S. Y. , King , A. E. , Cass , C. E. and Young , J. D. 2004 . The equilibrative nucleoside transporter family, SLC29 . Pflugers Arch. , 447 ( 5 ) : 735 – 743 .
   PubMed Web of Science ®Google Scholar
• Gray , J. H. , Owen , R. P. and Giacomini , K. M. 2004 . The concentrative nucleoside transporter family, SLC28 . Pflugers Arch. , 447 ( 5 ) : 728 – 734 .
   PubMed Web of Science ®Google Scholar
• Sabini , E. , Ort , S. , Monnerjahn , C. , Konrad , M. and Lavie , A. 2003 . Structure of human dCK suggests strategies to improve anticancer and antiviral therapy . Nat. Struct. Biol. , 10 ( 7 ) : 513 – 59 .
   PubMedGoogle Scholar
• Galmarini , C. M. , Mackey , J. R. and Dumontet , C. 2001 . Nucleoside analogues: mechanisms of drug resistance and reversal strategies . Leukemia , 15 ( 6 ) : 875 – 890 .
   PubMed Web of Science ®Google Scholar
• Spychala , J. , Madrid-Marina , V. and Fox , I. H. 1989 . Evidence for “low Km” and “high Km” soluble 5′-nucleotidases in human tissues and rat liver . Adv. Exp. Med. Biol. , 253B : 129 – 134 .
   PubMedGoogle Scholar
• Brockman , R. W. , Schabel , F. M. Jr. and Montgomery , J. A. 1977 . Biologic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-beta-D-arabinofuranosyladenine . Biochem. Pharmacol. , 26 ( 22 ) : 2193 – 2196 .
   PubMed Web of Science ®Google Scholar
• Reid , G. , Wielinga , P. , Zelcer , N. , De Haas , M. , Van Deemter , L. , Wijnholds , J. , Balzarini , J. and Borst , P. 2003 . Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5 . Mol. Pharmacol. , 63 ( 5 ) : 1094 – 1103 .
   PubMed Web of Science ®Google Scholar
• Pratt , S. , Shepard , R. L. , Kandasamy , R. A. , Johnston , P. A. , Perry , W. 3rd and Dantzig , A. H. 2005 . The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites . Mol Cancer Ther. , 4 ( 5 ) : 855 – 863 .
   PubMed Web of Science ®Google Scholar
• Guo , Y. , Kotova , E. , Chen , Z. S. , Lee , K. , Hopper-Borge , E. , Belinsky , M. G. and Kruh , G. D. 2003 . MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine . J. Biol. Chem. , 278 ( 32 ) : 29509 – 29514 .
   PubMed Web of Science ®Google Scholar
• Jordheim , L. , Galmarini , C. M. and Dumontet , C. 2003 . Drug resistance to cytotoxic nucleoside analogues . Curr. Drug Targets. , 4 ( 6 ) : 443 – 460 .
   PubMed Web of Science ®Google Scholar
• Mini , E. , Nobili , S. , Caciagli , B. , Landini , I. and Mazzei , T. 2006 . Cellular pharmacology of gemcitabine . Ann. Oncol. , 17 ( Suppl. 5 ) : v7 – v12 .
   PubMed Web of Science ®Google Scholar
• Baldwin , S. A. , Yao , S. Y. , Hyde , R. J. , Ng , A. M. , Foppolo , S. , Barnes , K. , Ritzel , M. W. , Cass , C. E. and Young , J. D. 2005 . Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes . J. Biol. Chem. , 280 ( 16 ) : 15880 – 15887 .
   PubMed Web of Science ®Google Scholar
• Barnes , K. , Dobrzynski , H. , Foppolo , S. , Beal , P. R. , Ismat , F. , Scullion , E. R. , Sun , L. , Tellez , J. , Ritzel , M. W. , Claycomb , W. C. , Cass , C. E. , Young , J. D. , Billeter-Clark , R. , Boyett , M. R. and Baldwin , S. A. 2006 . Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH . Circ. Res. , 99 ( 5 ) : 510 – 519 .
   PubMed Web of Science ®Google Scholar
• Molho-Pessach , V. , Lerer , I. , Abeliovich , D. , Agha , Z. , Abu Libdeh , A. , Broshtilova , V. , Elpeleg , O. and Zlotogorski , A. 2008 . The H syndrome is caused by mutations in the nucleoside transporter hENT3 . Am. J. Hum. Genet. , 83 ( 4 ) : 529 – 534 .
   PubMed Web of Science ®Google Scholar
• Govindarajan , R. , Leung , G. P. , Zhou , M. , Tse , C. M. , Wang , J. and Unadkat , J. D. 2009 . Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3 . Am J Physiol Gastrointest Liver Physiol. , 296 ( 4 ) : G910 – G922 .
   PubMed Web of Science ®Google Scholar
• Smith , K. M. , Ng , A. M. , Yao , S. Y. , Labedz , K. A. , Knaus , E. E. , Wiebe , L. I. , Cass , C. E. , Baldwin , S. A. , Chen , X. Z. , Karpinski , E. and Young , J. D. 2004 . Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes . J. Physiol. , 558 ( Pt 3 ) : 807 – 823 .
   PubMed Web of Science ®Google Scholar
• Hu , H. , Endres , C. J. , Chang , C. , Umapathy , N. S. , Lee , E. W. , Fei , Y. J. , Itagaki , S. , Swaan , P. W. , Ganapathy , V. and Unadkat , J. D. 2006 . Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3) . Mol. Pharmacol. , 69 ( 5 ) : 1542 – 1553 .
   PubMed Web of Science ®Google Scholar
• Lang , T. T. , Selner , M. , Young , J. D. and Cass , C. E. 2001 . Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells . Mol. Pharmacol. , 60 ( 5 ) : 1143 – 1152 .
   PubMed Web of Science ®Google Scholar
• Lu , H. , Chen , C. and Klaassen , C. 2004 . Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice . Drug Metab. Dispos. , 32 ( 12 ) : 1455 – 1461 .
   PubMed Web of Science ®Google Scholar
• Valdes , R. , Ortega , M. A. , Casado , F. J. , Felipe , A. , Gil , A. , Sanchez-Pozo , A. and Pastor-Anglada , M. 2000 . Nutritional regulation of nucleoside transporter expression in rat small intestine . Gastroenterology , 119 ( 6 ) : 1623 – 1630 .
   PubMed Web of Science ®Google Scholar
• Ritzel , M. W. , Ng , A. M. , Yao , S. Y. , Graham , K. , Loewen , S. K. , Smith , K. M. , Ritzel , R. G. , Mowles , D. A. , Carpenter , P. , Chen , X. Z. , Karpinski , E. , Hyde , R. J. , Baldwin , S. A. , Cass , C. E. and Young , J. D. 2001 . Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib) . J. Biol. Chem. , 276 ( 4 ) : 2914 – 2927 .
   PubMed Web of Science ®Google Scholar
• Dragan , Y. , Valdes , R. , Gomez-Angelats , M. , Felipe , A. , Javier Casado , F. , Pitot , H. and Pastor-Anglada , M. 2000 . Selective loss of nucleoside carrier expression in rat hepatocarcinomas . Hepatology , 32 ( 2 ) : 239 – 246 .
   PubMed Web of Science ®Google Scholar
• Pennycooke , M. , Chaudary , N. , Shuralyova , I. , Zhang , Y. and Coe , I. R. 2001 . Differential expression of human nucleoside transporters in normal and tumor tissue . Biochem Biophys. Res. Commun. , 280 ( 3 ) : 951 – 959 .
   PubMed Web of Science ®Google Scholar
• Farre , X. , Guillen-Gomez , E. , Sanchez , L. , Hardisson , D. , Plaza , Y. , Lloberas , J. , Casado , F. J. , Palacios , J. and Pastor-Anglada , M. 2004 . Expression of the nucleoside-derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors . Int. J. Cancer , 112 ( 6 ) : 959 – 966 .
   PubMed Web of Science ®Google Scholar
• Mackey , J. R. , Jennings , L. L. , Clarke , M. L. , Santos , C. L. , Dabbagh , L. , Vsianska , M. , Koski , S. L. , Coupland , R. W. , Baldwin , S. A. , Young , J. D. and Cass , C. E. 2002 . Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers . Clin. Cancer Res. , 8 ( 1 ) : 110 – 116 .
   PubMed Web of Science ®Google Scholar
• Soler , C. , Valdes , R. , Garcia-Manteiga , J. , Xaus , J. , Comalada , M. , Casado , F. J. , Modolell , M. , Nicholson , B. , MacLeod , C. , Felipe , A. , Celada , A. and Pastor-Anglada , M. 2001 . Lipopolysaccharide-induced apoptosis of macrophages determines the up-regulation of concentrative nucleoside transporters Cnt1 and Cnt2 through tumor necrosis factor-alpha-dependent and -independent mechanisms . J. Biol. Chem. , 276 ( 32 ) : 30043 – 30049 .
   PubMed Web of Science ®Google Scholar
• Soler , C. , Garcia-Manteiga , J. , Valdes , R. , Xaus , J. , Comalada , M. , Casado , F. J. , Pastor-Anglada , M. , Celada , A. and Felipe , A. 2001 . Macrophages require different nucleoside transport systems for proliferation and activation . FASEB J. , 15 ( 11 ) : 1979 – 1988 .
   PubMed Web of Science ®Google Scholar
• Aymerich , I. , Pastor-Anglada , M. and Casado , F. J. 2004 . Long term endocrine regulation of nucleoside transporters in rat intestinal epithelial cells . J. Gen. Physiol. , 124 ( 5 ) : 505 – 512 .
   PubMed Web of Science ®Google Scholar
• Gloeckner-Hofmann , K. , Guillen-Gomez , E. , Schmidtgen , C. , Porstmann , R. , Ziegler , R. , Stoss , O. , Casado , F. J. , Ruschoff , J. and Pastor-Anglada , M. 2006 . Expression of the high-affinity fluoropyrimidine-preferring nucleoside transporter hCNT1 correlates with decreased disease-free survival in breast cancer . Oncology , 70 ( 3 ) : 238 – 244 .
   PubMed Web of Science ®Google Scholar
• Mackey , J. R. , Galmarini , C. M. , Graham , K. A. , Joy , A. A. , Delmer , A. , Dabbagh , L. , Glubrecht , D. , Jewell , L. D. , Lai , R. , Lang , T. , Hanson , J. , Young , J. D. , Merle-Beral , H. , Binet , J. L. , Cass , C. E. and Dumontet , C. 2005 . Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations . Blood , 105 ( 2 ) : 767 – 774 .
   PubMed Web of Science ®Google Scholar
• Mackey , J. R. , Mani , R. S. , Selner , M. , Mowles , D. , Young , J. D. , Belt , J. A. , Crawford , C. R. and Cass , C. E. 1998 . Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines . Cancer Res. , 58 ( 19 ) : 4349 – 5437 .
   PubMed Web of Science ®Google Scholar
• Gourdeau , H. , Clarke , M. L. , Ouellet , F. , Mowles , D. , Selner , M. , Richard , A. , Lee , N. , Mackey , J. R. , Young , J. D. , Jolivet , J. , Lafreniere , R. G. and Cass , C. E. 2001 . Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines . Cancer Res. , 61 ( 19 ) : 7217 – 7224 .
   PubMed Web of Science ®Google Scholar
• Zimmerman , E. I. , Huang , M. , Leisewitz , A. V. , Wang , Y. , Yang , J. and Graves , L. M. 2009 . Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells . FEBS Lett. , 583 ( 2 ) : 425 – 429 .
   PubMed Web of Science ®Google Scholar
• Cai , J. , Damaraju , V. L. , Groulx , N. , Mowles , D. , Peng , Y. , Robins , M. J. , Cass , C. E. and Gros , P. 2008 . Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells . Cancer Res. , 68 ( 7 ) : 2349 – 2357 .
   PubMed Web of Science ®Google Scholar
• Molina-Arcas , M. , Moreno-Bueno , G. , Cano-Soldado , P. , Hernandez-Vargas , H. , Casado , F. J. , Palacios , J. and Pastor-Anglada , M. 2006 . Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5’-DFUR in breast cancer MCF7 cells . Biochem. Pharmacol. , 72 ( 12 ) : 1646 – 1656 .
   PubMed Web of Science ®Google Scholar
• Mata , J. F. , Garcia-Manteiga , J. M. , Lostao , M. P. , Fernandez-Veledo , S. , Guillen-Gomez , E. , Larrayoz , I. M. , Lloberas , J. , Casado , F. J. and Pastor-Anglada , M. 2001 . Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug . Mol. Pharmacol. , 59 ( 6 ) : 1542 – 158 .
   PubMed Web of Science ®Google Scholar
• Garcia-Manteiga , J. , Molina-Arcas , M. , Casado , F. J. , Mazo , A. and Pastor-Anglada , M. 2003 . Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2′,2′-difluorodeoxycytidine- induced cytotoxicity . Clin. Cancer Res. , 9 ( 13 ) : 5000 – 5008 .
   PubMed Web of Science ®Google Scholar
• Cano-Soldado , P. , Molina-Arcas , M. , Alguero , B. , Larrayoz , I. , Lostao , M. P. , Grandas , A. , Casado , F. J. and Pastor-Anglada , M. 2008 . Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells . Biochem. Pharmacol. , 75 ( 3 ) : 639 – 648 .
   PubMed Web of Science ®Google Scholar
• Gati , W. P. , Paterson , A. R. , Larratt , L. M. , Turner , A. R. and Belch , A. R. 1997 . Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein . Blood , 90 ( 1 ) : 346 – 353 .
   PubMed Web of Science ®Google Scholar
• Galmarini , C. M. , Thomas , X. , Calvo , F. , Rousselot , P. , Rabilloud , M. , El Jaffari , A. , Cros , E. and Dumontet , C. 2002 . In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia . Br. J. Haematol. , 117 ( 4 ) : 860 – 868 .
   PubMed Web of Science ®Google Scholar
• Hubeek , I. , Stam , R. W. , Peters , G. J. , Broekhuizen , R. , Meijerink , J. P. , van Wering , E. R. , Gibson , B. E. , Creutzig , U. , Zwaan , C. M. , Cloos , J. , Kuik , D. J. , Pieters , R. and Kaspers , G. J. 2005 . The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia . Br. J. Cancer , 93 ( 12 ) : 1388 – 11394 .
   PubMed Web of Science ®Google Scholar
• Marce , S. , Molina-Arcas , M. , Villamor , N. , Casado , F. J. , Campo , E. , Pastor-Anglada , M. and Colomer , D. 2006 . Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma . Haematologica , 91 ( 7 ) : 895 – 902 .
   PubMed Web of Science ®Google Scholar
• Molina-Arcas , M. , Bellosillo , B. , Casado , F. J. , Montserrat , E. , Gil , J. , Colomer , D. and Pastor-Anglada , M. 2003 . Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia . Blood , 101 ( 6 ) : 2328 – 2334 .
   PubMed Web of Science ®Google Scholar
• Lopez-Guerra , M. , Trigueros-Motos , L. , Molina-Arcas , M. , Villamor , N. , Casado , F. J. , Montserrat , E. , Campo , E. , Colomer , D. and Pastor-Anglada , M. 2008 . Identification of TIGAR in the equilibrative nucleoside transporter 2-mediated response to fludarabine in chronic lymphocytic leukemia cells . Haematologica , 93 ( 12 ) : 1843 – 1851 .
   PubMed Web of Science ®Google Scholar
• Rozman , C. and Montserrat , E. 1995 . Chronic lymphocytic leukemia . N. Engl. J. Med. , 333 ( 16 ) : 1052 – 1057 .
   PubMed Web of Science ®Google Scholar
• Stoetzer , O. J. , Pogrebniak , A. , Scholz , M. , Pelka-Fleischer , R. , Gullis , E. , Darsow , M. , Nussler , V. and Wilmanns , W. 1999 . Drug-induced apoptosis in chronic lymphocytic leukemia . Leukemia , 13 ( 11 ) : 1873 – 1880 .
   PubMed Web of Science ®Google Scholar
• Spratlin , J. , Sangha , R. , Glubrecht , D. , Dabbagh , L. , Young , J. D. , Dumontet , C. , Cass , C. , Lai , R. and Mackey , J. R. 2004 . The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma . Clin. Cancer Res. , 10 ( 20 ) : 6956 – 6961 .
   PubMed Web of Science ®Google Scholar
• Giovannetti , E. , Del Tacca , M. , Mey , V. , Funel , N. , Nannizzi , S. , Ricci , S. , Orlandini , C. , Boggi , U. , Campani , D. , Del Chiaro , M. , Iannopollo , M. , Bevilacqua , G. , Mosca , F. and Danesi , R. 2006 . Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine . Cancer Res. , 66 ( 7 ) : 3928 – 3935 .
   PubMed Web of Science ®Google Scholar
• Farrell , J. J. , Elsaleh , H. , Garcia , M. , Lai , R. , Ammar , A. , Regine , W. F. , Abrams , R. , Benson , A. B. , Macdonald , J. , Cass , C. E. , Dicker , A. P. and Mackey , J. R. 2009 . Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer . Gastroenterology , 136 ( 1 ) : 187 – 195 .
   PubMed Web of Science ®Google Scholar
• Tsang , R. Y. , Santos , C. , Ghosh , S. , Dabbagh , L. , King , K. , Young , J. , Cass , C. E. , Mackey , J. R. and Lai , R. 2008 . Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia . Mod. Pathol. , 21 ( 11 ) : 1387 – 1393 .
   PubMed Web of Science ®Google Scholar
• Errasti-Murugarren , E. , Molina-Arcas , M. , Casado , F. J. and Pastor-Anglada , M. 2009 . A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter-3 (hCNT3) protein localized in the endoplasmic reticulum . FASEB J. , 23 ( 1 ) : 172 – 182 .
   PubMed Web of Science ®Google Scholar
• Myers , S. N. , Goyal , R. K. , Roy , J. D. , Fairfull , L. D. , Wilson , J. W. and Ferrell , R. E. 2006 . Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1 . Pharmacogenet. Genomics , 16 ( 5 ) : 315 – 320 .
   PubMed Web of Science ®Google Scholar
• Nakano , Y. , Tanno , S. , Koizumi , K. , Nishikawa , T. , Nakamura , K. , Minoguchi , M. , Izawa , T. , Mizukami , Y. , Okumura , T. and Kohgo , Y. 2007 . Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells . Br. J. Cancer , 96 ( 3 ) : 457 – 463 .
   PubMed Web of Science ®Google Scholar
• Andersson , R. , Aho , U. , Nilsson , B. I. , Peters , G. J. , Pastor-Anglada , M. , Rasch , W. and Sandvold , M. L. 2009 . Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutions . Scand. J. Gastroenterol. , : 1 – 5 .
   Web of Science ®Google Scholar